# EUGIA Pharma Specialities Limited – FDA Inspection, Feb 27, 2026

Source: https://www.keypedia.com/records/fda_inspections/eugia-pharma-specialities-limited/7df17aa7-6253-487f-94ca-41e6ec737792
Source feed: FDA_Inspections

> FDA inspection 1304662 of EUGIA Pharma Specialities Limited, February 27, 2026. 4 citations under 21 CFR part 211. Form 483 issued. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1304662
- Company Name: EUGIA Pharma Specialities Limited
- Inspection Date: 2026-02-27
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Office of Inspections and Investigations
- Citation Count: 4

## Related Documents

- FDA Inspection 1234157 - 2023-07-26
- FDA Inspection 1234762 - 2022-11-25
- [FDA Inspection 1100694 - 2019-08-28](https://www.keypedia.com/records/fda_inspections/eugia-pharma-specialities-limited/a3d012ab-26cd-4cdb-9436-f0f8ba443dac)
- FDA Inspection 1057278 - 2018-06-08
- FDA Inspection 1039097 - 2017-12-14

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/joseph-a-piechocki/1977a57b-4976-4b01-b8da-66a84b26e803)
- [FDA Associated Person](https://www.keypedia.com/people/matthew-b-casale/e78481c6-5fbd-4723-a79c-167176395af8)

Company: https://www.keypedia.com/companies/eugia-pharma-specialities-limited/7c9f680c-5d29-42a0-a496-02fd4761792b

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8